In colorectal cancer, SIRPα-expressing TAMs suppress antitumor responses independently of CD47, whereas SIRPα-deficient macrophages enhance CD8+ T cell activation, particularly when combined with radiotherapy [248, 249]. This evidence concerns the gene SIRPA and colorectal cancer.